SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001860782-23-000125
Filing Date
2023-12-01
Accepted
2023-12-01 06:40:35
Documents
15
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A tsvt-20221231.htm   iXBRL 10-K/A 44637
2 EX-31.1 tsvt-fy202210xkexhibit311.htm EX-31.1 8823
3 EX-31.2 tsvt-fy202210xkexhibit312.htm EX-31.2 9030
  Complete submission text file 0001860782-23-000125.txt   277722

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tsvt-20221231.xsd EX-101.SCH 2539
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tsvt-20221231_lab.xml EX-101.LAB 40536
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tsvt-20221231_pre.xml EX-101.PRE 21508
9 EXTRACTED XBRL INSTANCE DOCUMENT tsvt-20221231_htm.xml XML 5565
Mailing Address 60 BINNEY STREET CAMBRIDGE MA 02210
Business Address 60 BINNEY STREET CAMBRIDGE MA 02210 339-499-9300
2seventy bio, Inc. (Filer) CIK: 0001860782 (see all company filings)

IRS No.: 863658454 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-40791 | Film No.: 231457492
SIC: 2834 Pharmaceutical Preparations